Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Cryptococcosis is a life-threatening disease caused by Cryptococcus neoformans or C. gattii. Neutralizing autoantibodies (auto-Abs) against granulocyte-macrophage colony-stimulating factor (GM-CSF) in otherwise healthy adults with cryptococcal meningitis have been described since 2013. We searched for neutralizing auto-Abs in sera collected from Colombian patients with non-HIV-associated cryptococcosis in a retrospective national cohort from 1997 to 2016.
Methods: We reviewed clinical and laboratory records and assessed the presence of neutralizing auto-Abs against GM-CSF in 30 HIV negative adults with cryptococcosis (13 caused by C. gattii and 17 caused by C. neoformans).
Results: We detected neutralizing auto-Abs against GM-CSF in the sera of 10 out of 13 (77%) patients infected with C. gattii and one out of 17 (6%) patients infected with C. neoformans.
Conclusions: We report eleven Colombian patients diagnosed with cryptococcosis who had auto-Abs that neutralize GM-CSF. Among these patients, ten were infected with C. gattii and only one with C. neoformans.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249431 | PMC |
| http://dx.doi.org/10.1007/s10875-024-01757-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
When Skin Reactions Interrupt Bone Therapy: Severe Cutaneous Adverse Reaction to Romosozumab Leading to Treatment Discontinuation.
Eur J Case Rep Intern Med
August 2025
General medicine department, Universidad de Cartagena, Cartagena, Colombia.
Background: Romosozumab is a sclerostin-inhibiting monoclonal antibody that is effective and safe for anabolic treatment in patients with osteoporosis. Its main adverse effects are local; the severity of these injection-site reactions in clinical trials was generally mild.
Case Report: We present a case of a 71-year-old Colombian woman with osteoporosis at very high risk of fractures with no relevant history of drug allergies.
Low Frequency of Dementia with Lewy Bodies Diagnosis in a Colombian Memory Clinic.
Mov Disord Clin Pract
September 2025
Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Background: The global burden of dementia is increasing, particularly in low- and middle-income countries. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia but remains underreported and frequently misdiagnosed. Its prevalence in Latin America is largely unknown.
View Article and Find Full Text PDFGenetic testing enhances diagnosis in critically ill neonates: insights from the first Colombian cohort.
Front Pediatr
August 2025
Laboratorio Clínico Especializado, Clínica Universitaria Colombia, Clínica Colsanitas, Bogotá, Colombia.
Introduction: The integration of genetic testing in pediatrics has advanced significantly in recent years. The incorporation of technologies such as Next Generation Sequencing (NGS) and array-based Comparative Genomic Hybridization (aCGH) in increasingly younger patients has accelerated the transition toward precision medicine.
Methods: This retrospective cross-sectional study (January 2021-June 2024) included 187 neonates (≤90 days old) from the NICUs of the Clínica Colsanitas network in Bogotá, Colombia and evaluate the diagnostic yield for genomic testing comprising 82 Whole Exome Sequencing (WES) and 125 aCGH tests, with 18 patients undergoing both.
Clinical and Procedural Characteristics of Patients Undergoing Endobronchial Ultrasound-Guided Transbronchial Mediastinal Cryobiopsy (CryoEBUS): A Descriptive Study in a Colombian Population.
Cureus
August 2025
Epidemiology and Public Health, Universidad de La Sabana, Chía, COL.
Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy (CryoEBUS) is an emerging minimally invasive technique that provides larger, better-preserved samples compared to conventional needle aspiration, improving suitability for histopathological and molecular testing. This retrospective study aimed to characterize the clinical profile, procedural aspects, and diagnostic yield of CryoEBUS in patients undergoing biopsy for mediastinal lesions. Fifty-nine patients underwent CryoEBUS.
View Article and Find Full Text PDFFrom guidelines to practice: LDL-C achievement in very high cardiovascular risk patients - analysis of the EDHIPO MARCA registry.
Lipids Health Dis
September 2025
Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Background: Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with dyslipidemia playing a key role in its progression. Despite advances in lipid-lowering therapy (LLT), LDL-C (Low-Density Lipoprotein Cholesterol) goal achievement remains suboptimal. This study evaluated LDL-C goal attainment in Colombian patients with very high cardiovascular risk (CVR) due to coronary artery disease (CAD) following ESC/EAS guidelines updates.
View Article and Find Full Text PDF